Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
3-alpha-hydroxysteroid dehydrogenase is an enzyme of the aldo-keto reductase superfamily that catalyzes the reversible conversion of 3-ketosteroids to 3α-hydroxysteroids, modulating the biological activity of androgens, estrogens, and progestins[1][5][9]. The enzyme exists in multiple isoforms (notably AKR1C1, AKR1C2, AKR1C3, and AKR1C4 in humans), each displaying unique tissue distribution and substrate specificity. By altering the occupancy of steroid hormone receptors, 3α-HSDs are central to hormone-dependent cellular processes, regulation of metabolism, and pathological states such as cancer and endocrine disorders. Structure-function studies highlight a conserved catalytic mechanism and a central role in steroid hormone balance, making this enzyme family a potential target for selective chemical inhibition[1][3][5][9].
Competitive inhibition of ketosteroid reduction/oxidation active site Alteration of receptor ligand availability (by changing steroid levels, affecting downstream hormone signaling)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 3-alpha-hydroxysteroid dehydrogenase (3α-HSD).